Sabra Healthcare REIT Inc. (SBRA) PT Raised to $14 at Citi
Tweet
Share
E-mailGet Alerts SBRA Hot Sheet
Price: $20.63 +0.44%
Rating Summary:
10 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Rating Summary:
10 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Join SI Premium – FREE
Citi analyst Nicholas Joseph raised the price target on Sabra Healthcare REIT Inc. (NASDAQ: SBRA) to $14.00 (from $10.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- iQIYI (IQ) PT Lowered to $1.20 at JPMorgan
- Eclat Textile Co Ltd (1476:TT) PT Lowered to NT$547 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
